Hält derzeit Positionen bei Clearside Biomedical Inc and BioCryst Pharmaceuticals Inc
Position | Company | Period |
---|---|---|
Director | Clearside Biomedical Inc | 21. April 2020 - |
Independent Director | BioCryst Pharmaceuticals Inc | 20. Januar 2012 - |
Independent Director | Cubist Pharmaceuticals LLC | 12. Juni 2008 - 21. Januar 2015 |
Suchen
Datum der Benachrichtigung | Datum der Transaktion | K/V Art der Transaktion |
Anz. der Aktien Kurs Wert |
Anzahl der Aktien | Kurs | Gesamtwert | Details | |
---|---|---|---|---|---|---|---|---|
2023-10-04 | 2023-10-03 |
Clearside Biomedical Inc
(CLSD)
|
K Kauf |
10.000
+12.0%
0,868.600 USD |
10.000 +12.0% | 0,86 | 8.600 USD | |
2023-06-15 | 2023-06-14 |
BioCryst Pharmaceuticals Inc
(BCRX)
|
V Verkauf |
12.866
-13.6%
8,04103.443 USD |
12.866 -13.6% | 8,04 | 103.443 USD | |
2022-11-21 | 2022-11-17 |
Clearside Biomedical Inc
(CLSD)
|
K Kauf |
30.000
+56.6%
1,3339.900 USD |
30.000 +56.6% | 1,33 | 39.900 USD | |
2021-10-19 | 2021-10-15 |
BioCryst Pharmaceuticals Inc
(BCRX)
|
GV Geplanter Verkauf |
105.000
-61.7%
15,401.617.000 USD |
105.000 -61.7% | 15,40 | 1.617.000 USD | |
2021-08-17 | 2021-08-16 |
Clearside Biomedical Inc
(CLSD)
|
K Kauf |
3.000
+30.0%
5,6817.040 USD |
3.000 +30.0% | 5,68 | 17.040 USD | |
2021-06-14 | 2021-06-10 |
BioCryst Pharmaceuticals Inc
(BCRX)
|
GV Geplanter Verkauf |
23.333
-26.4%
16,86393.394 USD |
23.333 -26.4% | 16,86 | 393.394 USD | |
2021-03-15 | 2021-03-12 |
Clearside Biomedical Inc
(CLSD)
|
K Kauf |
5.000
+100.0%
3,1115.525 USD |
5.000 +100.0% | 3,11 | 15.525 USD | |
2020-05-21 | 2020-05-20 |
Clearside Biomedical Inc
(CLSD)
|
K Kauf |
5.000
+inf%
1,859.250 USD |
5.000 +inf% | 1,85 | 9.250 USD | |
2018-12-17 | 2018-12-17 |
PhaseBio Pharmaceuticals Inc
(PHAS)
|
K Kauf |
1.000
+inf%
4,464.460 USD |
1.000 +inf% | 4,46 | 4.460 USD |